Učitavanje...
Hypoxia-activated prodrugs and redox-responsive nanocarriers
Hypoxia is one of the marked features of malignant tumors, which is associated with several adaptation changes in the microenvironment of tumor cells. Therefore, targeting tumor hypoxia is a research hotspot for cancer therapy. In this review, we summarize the developing chemotherapeutic drugs for t...
Spremljeno u:
| Izdano u: | Int J Nanomedicine |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6202002/ https://ncbi.nlm.nih.gov/pubmed/30425475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S173431 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|